Welcome to CURE's Annual Cancer Guide

Article

Involving patients in the decisionmaking process is an important and welcome trend, because it incorporates their values and preferences in situations where there are no black-and-white answers as to which path is best.

A CANCER DIAGNOSIS CAN transform a person’s life in an instant. During this time of shock and disbelief, crucial treatment decisions must be made. Involving patients in the decisionmaking process is an important and welcome trend, because it incorporates their values and preferences in situations where there are no blackand- white answers as to which path is best.

This requires that the patient, family and friends be as informed as possible about the nature of the disease and the proposed care plan. Having the right tools and the ability to use them quickly and confidently can be quite a challenge, and not one that patients should have to confront alone.

The 11th edition of CURE®’s Annual Cancer Guide for the Newly Diagnosed, produced in partnership with the American Cancer Society (ACS), CancerCare, the Cancer Support Community and the Patient Access Network Foundation, provides a framework for understanding how cancers are diagnosed and staged, and for coping with emotions that arise after a cancer diagnosis.

Treatments, and their benefits and side effects, are discussed, as are the rapid evolution of targeted biologic drugs and immunotherapies, and refinements in surgical and radiation techniques. Throughout the guide, survivors share advice on how to navigate the various phases of the cancer experience. A glossary of terms helps readers become familiar with the language of cancer.

Resources for a variety of situations and cancer types are also listed. The team of writers, editors and illustrators at CURE® magazine, along with their collaborators at the patient advocacy groups, have delivered a timely and useful handbook that offers proven guidance through a difficult time.

In this edition, we have added information on integrative medicine — a movement that is becoming stronger and more embraced by patients and the medical community. These approaches, which include acupuncture, yoga and meditation, are being studied with more rigor and offered in coordination with other medical care.

The guide also shares advice on how to communicate a cancer diagnosis and health updates to family members. The latest information about cancer in childhood is covered, as are the issues facing adolescents and young adults who develop cancer. This unique population experiences cancer types seen in both younger and older people, but faces them while transitioning into adulthood, work life and family planning.

For more than a decade, CURE® has combined science and humanity to promote learning, awareness and discourse about the challenges of cancer and the opportunities to improve options for patients and their loved ones. Quarterly and special issues focus on specific cancer types and highlight rapidly advancing science, technology and research, accompanied by insights about the emotional, practical and financial aspects of cancer — all of which are interrelated.

A subscription to CURE® magazine is free for cancer patients, survivors and caregivers, as is the rich array of information we offer at curetoday. com, including breaking news, videos and podcasts. In our unique way, we hope to make cancer understandable, and to support patients and the loved ones who care for them through every phase of the journey.

DEBU TRIPATHY, M.D.Editor-in-Chief, CURE® MagazineProfessor of MedicineChair, Department of Breast Medical OncologyThe University of Texas MD Anderson Cancer Center

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content